Cholinesterase inhibitors for mild cognitive impairment-Reference-Cited by-同舟云学术

Cholinesterase inhibitors for mild cognitive impairment

Published:2012-09-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Russ Tom C¹,Morling Joanne R²

Affiliation:

1. University of Edinburgh; Division of Psychiatry; Kennedy Tower, Royal Edinburgh Hospital Morningside Terrace Edinburgh UK EH10 5HF

2. University of Nottingham; Division of Epidemiology and Public Health; C120, Clinical Sciences Building - Ph2 City Hospital Campus, Hucknall Road Nottingham UK NG5 1PB

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD009132.pub2/fullpdf

Reference87 articles.

1. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial;Doody;Neurology,2009

2. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study;Feldman;Lancet Neurology,2007

3. Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study;Koontz;American Journal of Alzheimer's Disease and Other Dementias,2005

4. A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease;Narasimhalu;Acta Neurologica Scandinavica,2010

5. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI;Peters;Journal of Nutrition, Health & Aging,2012

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of multicomponent exercise on cognitive function in persons with mild cognitive impairment: A systematic review and meta-analysis;International Journal of Nursing Studies;2024-10

2. Identification of profiles associated with conversions between the Alzheimer’s disease stages, using a machine learning approach;Alzheimer's Research & Therapy;2024-07-26

3. Effect of Treatment of the Cholinergic Precursor Choline Alphoscerate in Mild Cognitive Dysfunction: A Randomized Controlled Trial;Medicina;2024-06-01

4. The Role of the Gut Microbiome in Health and Disease in the Elderly;Current Gastroenterology Reports;2024-04-20

5. Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild cognitive impairment: a meta-analysis of randomized controlled trials;European Journal of Nutrition;2024-02-01